Mission Creek Capital Partners, Inc. Zoetis Inc. Transaction History

Mission Creek Capital Partners, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $5,300 - $7,003	-35 Reduced 3.03%	1,121 $221,000
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $22,563 - $26,023	-135 Reduced 10.46%	1,156 $201,000
Q1 2023 May 12, 2023	BUY	$145.48 - $175.02 $187,814 - $225,950	1,291 New	1,291 $214,000
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $9,684 - $12,351	-50 Reduced 3.73%	1,291 $315,000
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $47,322 - $52,422	-250 Reduced 15.71%	1,341 $260,000
Q2 2021 Aug 13, 2021	SELL	$155.9 - $187.99 $23,385 - $28,198	-150 Reduced 8.62%	1,591 $296,000
Q1 2021 May 14, 2021	SELL	$144.0 - $169.39 $14,400 - $16,939	-100 Reduced 5.43%	1,741 $274,000
Q1 2020 May 14, 2020	SELL	$92.66 - $144.94 $5,559 - $8,696	-60 Reduced 3.16%	1,841 $217,000
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $220,991 - $253,308	1,901 New	1,901 $252,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.